Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
30 CNY
-0.3%
Updated:
May 15, 2024
Beijing Hotgen Biotech Co Ltd
Interest Income Expense
|
Beijing Hotgen Biotech Co Ltd
Interest Income Expense Peer Comparison
Comparables:
603259
300759
2269
300347
1548
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Interest Income Expense
¥45.2m
|
CAGR 3-Years
128%
|
CAGR 5-Years
103%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Interest Income Expense
¥103.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Interest Income Expense
¥34.9m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Interest Income Expense
¥80.2m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Interest Income Expense
¥612.2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
35%
|
CAGR 10-Years
48%
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Interest Income Expense
$51.5m
|
CAGR 3-Years
83%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Interest Income Expense?
Interest Income Expense
45.2m
CNY
45.2m
CNY
Based on the financial report for Dec 31, 2022, Beijing Hotgen Biotech Co Ltd's Interest Income Expense amounts to 45.2m CNY.
What is Beijing Hotgen Biotech Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
103%
103%
Over the last year, the Interest Income Expense growth was 111%. The average annual Interest Income Expense growth rates for Beijing Hotgen Biotech Co Ltd have been 128% over the past three years , 103% over the past five years .
You don't have any saved screeners yet
